(2022) Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder. Clinical Genetics. pp. 98-109.
![]() |
Text
CGE-102-98.pdf Download (9MB) |
Abstract
Biallelic variants of the gene encoding for the zinc-finger protein 142 (ZNF142) have recently been associated with intellectual disability (ID), speech impairment, seizures, and movement disorders in nine individuals from five families. In this study, we obtained phenotype and genotype information of 26 further individuals from 16 families. Among the 27 different ZNF142 variants identified in the total of 35 individuals only four were missense. Missense variants may give a milder phenotype by changing the local structure of ZF motifs as suggested by protein modeling; but this correlation should be validated in larger cohorts and pathogenicity of the missense variants should be investigated with functional studies. Clinical features of the 35 individuals suggest that biallelic ZNF142 variants lead to a syndromic neurodevelopmental disorder with mild to moderate ID, varying degrees of delay in language and gross motor development, early onset seizures, hypotonia, behavioral features, movement disorders, and facial dysmorphism. The differences in symptom frequencies observed in the unpublished individuals compared to those of published, and recognition of previously underemphasized facial features are likely to be due to the small sizes of the previous cohorts, which underlines the importance of larger cohorts for the phenotype descriptions of rare genetic disorders. © 2022 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.
Item Type: | Article |
---|---|
Keywords: | anticonvulsive agent; transcription factor CTCF; unclassified drug; zinc finger protein; zinc finger protein 142; zinc ion, absence seizure; adolescent; adult; aggression; allele; antisocial personality disorder; anxiety disorder; Article; ataxia; attention deficit hyperactivity disorder; autism; behavior disorder; child; childhood; clinical article; clinical examination; clinical feature; clinician; cognition; cognition assessment; cognitive function test; cohort analysis; controlled study; corpus callosum; crystal structure; demyelinating disease; developmental delay; disease severity; DSM-IV; dystonia; electroencephalogram; epilepsy; epileptic state; exon; face dysmorphia; facies; fatigue; female; fever; focal epilepsy; frameshift mutation; gene deletion; gene mutation; genotype; heterozygosity; high throughput sequencing; homozygosity; human; hypertelorism; indel mutation; infancy; intellectual impairment; intelligence quotient; language ability; language delay; language disability; male; mental disease; missense mutation; mother; motor dysfunction; mouse; muscle hypertonia; muscle hypotonia; myoclonus seizure; nonhuman; nonsense mediated mRNA decay; nonsense mutation; onset age; phenotype; preschool child; school child; sequence alignment; sex ratio; single nucleotide polymorphism array; sleep deprivation; static electricity; structural model; telecanthus; tonic clonic seizure; tremor; uniparental disomy; walking; walking difficulty; whole genome sequencing; wide based gait; young adult; complication; genetics; intellectual impairment; motor dysfunction; phenotype; seizure, Humans; Intellectual Disability; Movement Disorders; Neurodevelopmental Disorders; Phenotype; Seizures |
Page Range: | pp. 98-109 |
Journal or Publication Title: | Clinical Genetics |
Volume: | 102 |
Number: | 2 |
Publisher: | John Wiley and Sons Inc |
Depositing User: | ms soheila Bazm |
URI: | http://eprints.ssu.ac.ir/id/eprint/12405 |
Actions (login required)
![]() |
View Item |